Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unexpected periosteal bone apposition including newly embedded osteocytes occurs around a mouse calvaria critical defect, independently of the presence of biomaterials.

Scientific reports·2026
Same author

Impact of a newly opened mechanical thrombectomy center on stroke management: volume, delays, and clinical outcomes.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026
Same author

Generating Synthetic MR Perfusion Maps From DWI and FLAIR in Acute Ischemic Stroke: Development and External Validation of a Deep Learning Model.

Stroke·2026
Same author

Summary of Research: Cognition and Employment Status of People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-Year CLARIFY-MS Study.

Neurology and therapy·2026
Same author

Updated French OFSEP recommendations for multiple sclerosis MRI: alignment with the 2024 McDonald criteria.

Journal of neuroradiology = Journal de neuroradiologie·2026
Same author

Correction: Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two‑year Phase IV CLARIFY‑MS Study.

Neurology and therapy·2026

Related Experiment Video

Updated: Jul 10, 2026

In vitro Labeling of Human Embryonic Stem Cells for Magnetic Resonance Imaging
11:41

In vitro Labeling of Human Embryonic Stem Cells for Magnetic Resonance Imaging

Published on: August 3, 2008

How to trace stem cells for MRI evaluation?

Vincent Dousset1, Thomas Tourdias, Bruno Brochet

  • 1Laboratoire de Neurobiologie des Affections de la Myéline EA 2966 Université Victor Segalen Bordeaux 2, 146 rue Léo Saignat 33076 Bordeaux, France. vincent.dousset@chu-bordeaux.fr

Journal of the Neurological Sciences
|October 30, 2007
PubMed
Summary
This summary is machine-generated.

This review explores advanced imaging techniques for stem cell visualization, focusing on contrast agent design for brain applications. It discusses potential side effects of agents like iron oxide nanoparticles used in cell labeling.

More Related Videos

Tracking Superparamagnetic Iron Oxide-labeled Mesenchymal Stem Cells using MRI after Intranasal Delivery in a Traumatic Brain Injury Murine Model
10:03

Tracking Superparamagnetic Iron Oxide-labeled Mesenchymal Stem Cells using MRI after Intranasal Delivery in a Traumatic Brain Injury Murine Model

Published on: November 21, 2019

Labeling hESCs and hMSCs with Iron Oxide Nanoparticles for Non-Invasive in vivo Tracking with MR Imaging
09:06

Labeling hESCs and hMSCs with Iron Oxide Nanoparticles for Non-Invasive in vivo Tracking with MR Imaging

Published on: March 31, 2008

Related Experiment Videos

Last Updated: Jul 10, 2026

In vitro Labeling of Human Embryonic Stem Cells for Magnetic Resonance Imaging
11:41

In vitro Labeling of Human Embryonic Stem Cells for Magnetic Resonance Imaging

Published on: August 3, 2008

Tracking Superparamagnetic Iron Oxide-labeled Mesenchymal Stem Cells using MRI after Intranasal Delivery in a Traumatic Brain Injury Murine Model
10:03

Tracking Superparamagnetic Iron Oxide-labeled Mesenchymal Stem Cells using MRI after Intranasal Delivery in a Traumatic Brain Injury Murine Model

Published on: November 21, 2019

Labeling hESCs and hMSCs with Iron Oxide Nanoparticles for Non-Invasive in vivo Tracking with MR Imaging
09:06

Labeling hESCs and hMSCs with Iron Oxide Nanoparticles for Non-Invasive in vivo Tracking with MR Imaging

Published on: March 31, 2008

Area of Science:

  • Biomedical imaging
  • Stem cell biology
  • Nanotechnology

Background:

  • Visualizing stem cells is crucial for monitoring, controlling, and treating biological systems, especially the brain.
  • Identifying specific stem and precursor cells linked to clinical conditions requires precise imaging strategies.
  • Minimizing side effects during stem cell imaging necessitates careful selection of appropriate markers and contrast agents.

Purpose of the Study:

  • To review rational design approaches for contrast agents used in stem cell imaging.
  • To highlight applications of imaging techniques for stem cell visualization in biological systems.
  • To discuss potential pitfalls and side effects associated with contrast agents, particularly iron oxide nanoparticles.

Main Methods:

  • Review of existing literature on contrast agent design for stem cell imaging.
  • Analysis of imaging techniques for stem cell visualization and tracking.
  • Discussion of cell labeling strategies using contrast agents like iron oxide nanoparticles.

Main Results:

  • Examples of rational contrast agent design for effective stem cell imaging are presented.
  • The importance of marker selection for successful stem cell visualization is emphasized.
  • Potential adverse effects of iron oxide nanoparticles in cell labeling are critically examined.

Conclusions:

  • Advanced contrast agent design is key to advancing stem cell imaging applications.
  • Careful consideration of agent properties and potential side effects is essential for safe and effective stem cell therapies.
  • Further research into novel contrast agents and imaging modalities will improve stem cell monitoring and treatment.